Authors
Loading...
This study presents a multi-epitope mRNA vaccine targeting btHKU5-CoV-2, suggesting strong antigenicity and immunogenicity.
Zheng et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: